Zinc

Overview

Zinc is the most widely utilized transition metal cofactor in biology. Approximately 9-10% of the eukaryotic proteome and 5-6% of the bacterial proteome consists of zinc-binding proteins ^[1]. An estimated one-third to 40% of all proteins in a typical proteome are metalloproteins, with zinc and iron constituting the most abundant intracellular transition metals, reaching tens of millimolar total concentration ^[1]. Unlike copper and iron, zinc has a single biologically relevant oxidation state — Zn(II) — and does not undergo redox cycling, making it redox-inert and safe as a structural and catalytic cofactor.

What makes zinc singular among metals in this knowledge base is its dual role as both essential nutrient and antimicrobial weapon. The host immune system deliberately floods pathogens with toxic zinc concentrations inside phagosomes while simultaneously starving them of zinc at extracellular infection sites via calprotectin ^[2]. This dual strategy — withholding and weaponizing the same element — exploits the narrow window between zinc deficiency and zinc toxicity that all living cells must navigate.

Zinc is depleted in a striking number of disease states: cancer (breast, prostate, lung, pancreatic, esophageal, colorectal), type 2 diabetes, PCOS, autism spectrum disorder, postpartum depression, IBD, autoimmune thyroid disease, and Parkinson's disease. The elevated Cu/Zn ratio is emerging as a pan-disease biomarker across these conditions ^[3].

Biological Roles

Structural: The Zinc Finger Proteome

Zinc finger motifs are "mini-folds" that cannot fold without their metal cofactor ^[1]. These structural sites are found in DNA-binding transcription factors, RNA polymerases, and ribosomal proteins. Because 9-10% of the human proteome contains zinc-binding motifs (zinc fingers, RING domains), toxic metals such as lead, mercury, and cadmium that displace zinc from these sites have proteome-wide consequences ^[4], ^[5].

Catalytic: Nature's Preferred Hydrolytic Catalyst

Zinc(II) is incorporated into over 100 distinct structural enzyme superfamilies spanning all seven EC enzyme classes ^[1]. Key zinc-dependent enzymes include:

• Cu/Zn-SOD (SOD1) — superoxide dismutase providing antioxidant defense; zinc deficiency reduces capacity to neutralize reactive oxygen species ^[6]
• Matrix metalloproteinases (MMP-2, MMP-9) — tissue remodeling enzymes; excess zinc may promote MMP-mediated tissue invasion ^[7]
• Carbonic anhydrase — pH regulation
• Alkaline phosphatase — phosphate metabolism
• DNA and RNA polymerases — genome maintenance and transcription
• p53 tumor suppressor — contains a zinc-binding domain essential for DNA repair and apoptosis; zinc deficiency impairs p53-mediated tumor suppression ^[6]
• Gamma-secretase — modulates amyloid-beta production in the brain ^[8]

Regulatory: Allosteric Metal Signaling

Zinc functions as an allosteric regulator at regulatory metal sites. For example, Zn(II) inhibits protein tyrosine phosphatase 1B (PTP1B) with a dissociation constant in the low picomolar range, while Mg(II) activates the same enzyme ^[1]. This regulatory role extends to insulin signaling: ZnT8 transporter in pancreatic beta cells is critical for insulin hexamer storage and secretion, and ZnT8 mutations are associated with type 2 diabetes risk ^[9].

Immune Function

Zinc is required for T cell differentiation (CD4+/CD8+ ratio), NK cell activity, and cytokine regulation. Even minor serum fluctuations affect T cell levels ^[6]. In the tumor microenvironment, zinc depletion impairs T cell receptor signaling and cytotoxic function, contributing to immune evasion by tumors ^[10]. Zinc also adjusts excitatory/inhibitory neurotransmission via glutamate and GABA receptors ^[11].

Neurodevelopment

Zinc regulates key synaptic pathways implicated in autism spectrum disorder: the NLGN-NRXN-SHANK scaffold complex and the mTOR/PI3K pathway ^[4]. SHANK3, a critical synaptic scaffold protein, directly binds zinc to form functional scaffolds; zinc deficiency reduces SHANK3 scaffold formation and disrupts NMDA and AMPA receptor function ^[12]. Prenatal zinc deficiency causes ASD-like behavior in animal models ^[4].

Gut Barrier Integrity

Zinc enhances intestinal barrier function, reduces permeability, exerts anti-inflammatory effects, and promotes beneficial gut bacteria growth ^[13]. In preterm infants, zinc is essential for Paneth-cell defensin production and intestinal immunomodulation, contributing to protection against necrotizing enterocolitis ^[14].

Dietary and Environmental Sources

Dietary sources. Red meat, shellfish (oysters are the richest known food source), legumes, nuts, seeds, whole grains, and dairy. Foods high in zinc substantially overlap with high-nickel foods (nuts, whole grains, legumes, shellfish) ^[7].

Supplements. Zinc acetate, zinc gluconate, zinc sulfate. Doses in clinical studies range from 27 mg/day to 100 mg/day ^[11].

Fortified foods. Many cereals and infant formulas are zinc-fortified; infant formula zinc concentrations are a documented exposure route in early life ^[15].

Livestock feed. Zinc compounds are used as growth promoters and therapeutics in pig and poultry production at inclusion rates up to 30 times basal requirements in the EU, with 90% of in-feed zinc shed in livestock feces ^[16]. This creates significant environmental zinc contamination with consequences for soil microbiome composition and antimicrobial resistance selection.

Oral hygiene products. Zinc concentrations in toothpastes and mouthwashes range from 30 to 150 mM, leading to several hours of elevated oral zinc levels after application ^[17].

U-shaped dose-response. Both deficiency and excess are harmful; the therapeutic window is narrow. This U-shaped relationship has been confirmed across cardiovascular, cancer, and neurodevelopmental contexts.

Microbiome Interactions

This section contains content that does not appear on Wikipedia and represents one of WikiBiome's core contributions: understanding how zinc shapes microbial ecology, and how microbes have evolved to compete for and resist zinc.

Zinc as Selective Pressure on Gut Microbiota

Both zinc deficiency and excess reshape the gut microbiome in distinct, dose-dependent patterns. In a controlled mouse study, short-term zinc-deficient diets (0 mg/kg, 4 weeks) increased Proteobacteria and Desulfovibrio — established markers of dysbiosis and inflammation — while long-term high-zinc diets (150 mg/kg, 8 weeks) suppressed total SCFAs, butyric acid, acetic acid, and SCFA-producing genera ^[18]. Excess zinc (600 mg/kg) dramatically decreased microbial diversity (Shannon index) ^[18].

The microbial response follows a clear dose pattern:

Zinc status	Key microbial changes	Metabolic consequence
Deficiency (short-term)	Increased Proteobacteria, Desulfovibrio, Parasutterella	Decreased total metabolites [18]
Deficiency (long-term)	Increased Akkermansia, Blautia	Decreased valerate [18]
Moderate excess (short-term)	Increased Verrucomicrobia, Akkermansia	Variable [18]
Moderate excess (long-term)	Decreased Verrucomicrobia, decreased Lactobacillus reuteri	Markedly decreased all SCFAs [18]
High excess	Decreased diversity; Enterobacteriaceae bloom	Drug resistance pathways upregulated [18]

In zinc-deficient children, lower Bifidobacterium and higher pro-inflammatory metabolites have been observed ^[2]. Excess zinc (ZnO) in pigs decreased Clostridium spp. and Enterobacteriaceae, while chronic zinc excess in mice produced dysbiotic Enterobacteriaceae blooms and reduced SCFA-producing Ruminococcus ^[2].

The gut microbiome may also serve as a zinc sensor: approximately 20% of dietary zinc is absorbed by intestinal bacteria, so zinc status directly modulates gut microbiota composition ^[12]. Melainabacteria has been identified as a reliable phylum-level microbial biomarker for zinc status (AUC > 0.85), negatively correlated with serum zinc, while Desulfovibrio sp. ABHU2SB serves as a species-level biomarker (ROC AUC 0.8-0.91) ^[18].

Bacterial Zinc Acquisition Systems

Bacteria have evolved sophisticated machinery to acquire zinc from the host environment, especially during infection when the host restricts zinc availability:

• ZnuABC — an ATP-dependent ABC transporter found across Gram-negative pathogens; ZnuA is the periplasmic zinc-binding subunit, repressed by the Zur zinc-sensing regulator. In Campylobacter jejuni, znuABC inactivation prevents infection entirely ^[2]. In pseudomonas aeruginosa, znuA disruption significantly reduces virulence in infection models ^[19].
• Pseudopaline (ZrmABCD) — a "zincophore" (zinc-specific metallophore, analogous to siderophores for iron) produced by P. aeruginosa. Pseudopaline is synthesized intracellularly, secreted to scavenge extracellular zinc — including from host calprotectin — and reimported via TonB-dependent transport ^[19].
• Yersiniabactin — a metallophore originally characterized as a siderophore but which also chelates zinc and copper. Probiotic E. coli Nissle possesses yersiniabactin and resists calprotectin-induced zinc sequestration better than pathogenic Salmonella ^[2].

Bacterial Zinc Efflux and Resistance

Just as bacteria need zinc, they must also expel excess zinc to avoid toxicity:

• ZntA — a P-type ATPase zinc exporter found in Vibrio parahaemolyticus (induced ~19-fold by zinc) and many other Gram-negatives. ZntA-deficient bacteria accumulate intracellular zinc and become attenuated in virulence ^[20].
• CzcD — a zinc/cadmium exporter in Streptococcus pneumoniae and other species, essential for surviving host zinc flooding ^[21].
• CzcABCD — a resistance-nodulation-division (RND) efflux system in P. aeruginosa that exports excess Zn, Cd, and Co; upregulated upon macrophage phagocytosis, reflecting a response to phagosomal zinc poisoning ^[19].
• ZccE — a unique zinc exporter in Streptococcus mutans that confers high zinc tolerance; ZccE-deletion mutants become highly susceptible to zinc ^[17].
• Ccn sRNAs — five homologous small regulatory RNAs in S. pneumoniae that maintain the intracellular Zn:Mn ratio by reducing bioavailable free zinc. Deletion of all five Ccn sRNAs causes zinc hypersensitivity and attenuated virulence (median survival time from 43h to 67h in murine pneumonia) ^[21].

Co-Selection of Antibiotic Resistance

Environmental zinc contamination — particularly from livestock feed — drives co-selection of antimicrobial resistance. Zinc exposure selects for bacteria carrying efflux pumps and mobile genetic elements that confer resistance to both metals and antibiotics simultaneously ^[16]. In controlled dietary studies, high-zinc diets upregulated drug resistance and infectious disease KEGG pathways in the gut microbiome ^[18]. Heavy metal toxicity to composting microorganisms follows the order copper > zinc > cadmium, but zinc resistance required a longer lag period to develop than resistance to copper or cadmium ^[22].

Host Zinc Transport Shapes the Microbiome

Genetic variation in host zinc transporters directly influences gut microbial composition. The ZIP8 A391T variant (rs13107325), a Crohn's disease risk allele, reduces luminal zinc availability in the colon by altering metal ion homeostasis at the mucosal-luminal interface. Homozygous mutant mice showed reduced luminal iron, cobalt, copper, zinc, cadmium, and manganese, with age-dependent microbiome compositional shifts — the genotype-microbiome association R-squared increased from 3% at 2 months to 9% at 12 months ^[23]. Lactobacillus was reduced in mutant animals, while Staphylococcus, Rikenella, and Akkermansia were enriched at 12 months ^[23]. This is the first demonstration that a Crohn's-linked missense variant modulates colonic microbiome composition, positioning SLC39A8 A391T as a potential microbiome quantitative trait locus.

Nutritional Immunity: The Host's Zinc Weapons

Nutritional immunity — the host strategy of metal restriction to starve pathogens — extends far beyond iron. Zinc is both withheld from and weaponized against invading bacteria, making it central to innate immune defense.

Calprotectin-Mediated Zinc Sequestration

Calprotectin (S100A8/S100A9 heterodimer) is the host's primary extracellular zinc-sequestering weapon. It comprises 40-50% of neutrophil cytoplasmic protein content and can reach concentrations exceeding 1 mg/mL at infection sites ^[2]. Calprotectin chelates both zinc and manganese (and to a lesser extent iron), creating metal-depleted zones around infections that starve pathogens of essential cofactors ^[24].

The clinical consequence: at abscess sites, calprotectin renders staphylococcus aureus virtually devoid of manganese ^[2], while the simultaneous zinc restriction targets zinc-dependent virulence enzymes. This dual Zn/Mn restriction is particularly lethal because it simultaneously disables zinc-dependent metalloproteases and manganese-dependent superoxide dismutase, leaving pathogens both disarmed and defenseless against oxidative killing.

Phagosomal Zinc Flooding

Inside the phagosome, the strategy reverses: macrophages flood engulfed bacteria with toxic zinc concentrations via ZnT-family transporters. Host peptidoglycan recognition proteins (PGRPs) induce 60-100-fold increases in intracellular Zn(II) and Cu(I) in target bacteria ^[25]. Chelation of either zinc or copper completely abolished PGRP bactericidal activity, demonstrating that metal intoxication is a required component of immune killing, not a side effect ^[25].

The zinc concentrations achieved inside phagosomes exceed bacterial metal buffering capacity, triggering regulatory "mis-sensing" — bacterial metal sensors lose the ability to discriminate zinc from cobalt, mounting counterproductive stress responses that accelerate their own death ^[26].

Zinc Mis-Metallation as Killing Mechanism

The antimicrobial mechanism of zinc flooding operates through mis metallation — the displacement of correct metal cofactors from enzymes. The Irving-Williams series (Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II)) dictates that zinc binds more tightly than manganese or iron to almost any biological ligand ^[27]. When zinc concentrations exceed cellular buffering capacity, zinc displaces weaker-binding metals from their native enzymes:

Zinc displaces manganese from SOD. The most well-characterized example: zinc competitively inhibits manganese uptake through the PsaA permease in S. pneumoniae (EC50 = 30.2 uM Zn at 1 uM Mn). Manganese-starved pneumococcus loads its SOD with iron instead, rendering the enzyme inactive against superoxide and leaving the bacterium vulnerable to oxidative killing ^[28]. The Zn:Mn ratio — not absolute zinc concentration — determines bacterial vulnerability ^[28]. This ratio-dependent framework has been confirmed in S. pneumoniae Ccn sRNA mutants, where manganese supplementation or oxygen removal rescues zinc-dependent growth inhibition ^[21].

Zinc mis-metalates the PerR regulator. In Bacillus and Staphylococcus, zinc displaces the correct Mn/Fe cofactor from PerR, a peroxide-sensing transcriptional repressor. Mis-metalated PerR constitutively represses catalase while derepressing heme biosynthesis, flooding the cell with pro-oxidant heme and no antioxidant defense — a lethal positive feedback loop ^[29]. Zinc also inhibits cytochrome aa3 oxidase; bacteria survive only via the zinc-resistant cytochrome bd pathway ^[29].

Zinc mis-metalates cell wall biosynthesis enzymes. In Klebsiella pneumoniae, zinc ionophore treatment increased intracellular zinc while decreasing manganese, suppressing SOD activity and disrupting cell wall biosynthesis via mis-metallation of GlmU (the final enzyme in UDP-GlcNAc synthesis). Despite upregulated GlmU gene expression, the enzyme product was reduced — a signature of protein-level mis-metallation ^[30]. In acinetobacter baumannii, the zinc metallochaperone MigC modulates MurD (an essential peptidoglycan ligase); under host calprotectin-mediated zinc depletion, loss of MigC function sensitizes bacteria to beta-lactam antibiotics ^[31].

Zinc remodels the cell surface. In Caulobacter crescentus, zinc stress triggers outer membrane proteome remodeling via TonB-dependent receptors, exposing normally impermeable antibiotic binding sites and rendering the bacterium sensitive to vancomycin and bacitracin ^[32].

The Protective Mis-Metallation Paradox

Not all zinc mis-metallation is harmful to bacteria. In Riemerella anatipestifer, zinc accumulation paradoxically increases resistance to hydrogen peroxide and hypochlorite. Elevated intracellular zinc competitively inhibits iron binding to biomolecules that catalyze Fenton reactions, reducing ROS generation — a form of "protective mis-metallation" ^[33].

Invertebrate Nutritional Immunity

Host zinc restriction is not limited to mammals. Galleria mellonella (wax moth) larvae upregulate zinc transporters upon P. aeruginosa infection, mounting an active zinc redistribution response analogous to mammalian nutritional immunity ^[19], suggesting this defense strategy is an ancient, conserved feature of animal immunity.

Conditions Associated

Cancer (General Feature of Malignancy)

Low zinc levels are consistently reported across virtually all cancer types studied, making zinc deficiency a hallmark of cancer ^[6]. In the tumor microenvironment, zinc depletion impairs T cell receptor signaling and cytotoxic function, contributing to immune evasion ^[10].

• Breast cancer: Zn significantly lower in plasma/serum; SMD -2.09 (-3.27, -0.91). Zinc deficiency disrupts antioxidant defense via Cu/Zn-SOD ^[34], ^[35].
• Prostate cancer: Significantly decreased (0.51 vs 0.82 ug/mL, p < 0.005). Disrupted Zn transporter function enables malignant transformation ^[36].
• Lung cancer: Meta-analyses show significantly lower Zn in lung cancer patients. Zn shows VIP > 1 in PLS-DA separating disease groups ^[37].
• Pancreatic cancer: Urinary Zn significantly higher in PDAC (p = 0.02), reflecting disrupted ZnT/ZIP transporters. Zinc isotope fractionation shows PDAC patients preferentially excrete isotopically light zinc ^[38].
• Esophageal cancer: Most extensively studied; Zn deficiency promotes carcinogenesis by altering microRNA expression ^[6].
• Liver cancer: High Cu/Zn ratio predicts worse survival ^[6].
• Cu/Zn ratio: Elevated across virtually all cancer types in blood/serum — a general circulating cancer marker ^[3].

Autism Spectrum Disorder

A primary pathology of ASD may be trace metal imbalance characterized by lack of zinc during brain development. Zinc is consistently decreased in hair of ASD children — the most reproducible finding in ASD metallomics ^[4].

• Toxic metals (Pb, Hg, Cd) compete with Zn for protein binding sites on ~10% of the human proteome, creating functional zinc deficiency — proposed as the unifying mechanism linking toxic metal exposure to ASD gut and brain pathology ^[4], ^[13].
• 30-70% of children with ASD suffer GI disturbances; zinc deficiency produces overlapping gut pathologies with Hg, Cd, and Pb exposure: barrier dysfunction, increased permeability, gut inflammation, and microbiota dysbiosis ^[13].
• Meta-analytic confirmation: A 2024 meta-analysis (N = 706) confirmed significantly lower Zn in ASD children: MD = -6.707 (95% CI: -12.691, -0.722), p = 0.028, with moderate effect size (SMD = -0.498) ^[39].
• Metallome-ome cascade: Zn deficiency increases gut permeability, provokes IL-6 and GFAP-mediated inflammation, and may trigger NLRP3-driven neuroinflammation ^[12].
• Cu/Zn ratio elevation: Autistic individuals show significantly elevated plasma copper and Cu/Zn ratio. Copper decreased significantly after zinc therapy only in the GI disease subgroup, suggesting the gut is a critical site for copper-zinc competition ^[40].
• Hair vs serum discrepancy: A 2025 Chinese hair study (N = 181) found no significant hair zinc difference in ASD vs controls (p = 0.663), contrasting with blood/serum studies and potentially reflecting matrix-specific differences or regional dietary variation ^[41].
• Prenatal zinc-copper rhythm disruption: Altered Zn-Cu rhythms in fetal and postnatal tissue (measured via tooth-matrix biomarkers) are linked to ASD; phthalate exposure may mediate this disruption ^[42].

Type 2 Diabetes

Increased urinary Zn excretion leads to suboptimal blood Zn status, impairing insulin storage, secretion, and signaling ^[9]. ZnT8 transporter mutation is a T2D risk allele; zinc is critical for insulin hexamer formation in beta cells. Renal excretion-driven Zn depletion creates a vicious cycle of worsening metal dyshomeostasis ^[9].

PCOS

Lower Zn in PCOS (1350 vs 1598 ppb, p = 0.010), with Zn negatively correlated with fasting glucose ^[43]. No significant Cu/Zn ratio difference in one study ^[44], though the meta-analytic trend supports elevated Cu/Zn.

Postpartum Depression

Serum zinc dramatically lower in PPD cases: 21.03 vs 54.16 ug/dL in controls — a statistically significant and clinically striking difference ^[45]. Negative correlation between EPDS severity and serum zinc (dose-response relationship) ^[45].

Neurodegeneration

• Reduced serum and plasma Zn in PD patients (meta-analysis of 803 PD, 796 controls) ^[46].
• Zn transporter dysfunction observed in AD brains ^[8].
• Zn modulates gamma-secretase activity affecting amyloid-beta production ^[8].
• Paradox: Zinc rapidly precipitates amyloid-beta at physiological concentrations, and zinc enrichment in plaques is a consistent finding. Both zinc excess and deficiency may contribute to AD pathology ^[8], ^[46].
• Brain metallomic signatures — spatial distribution of Fe, Cu, Zn, Mn across specific regions — can differentiate dementia with Lewy bodies from Alzheimer's and Parkinson's disease dementia ^[47].
• Zinc-dependent metalloproteases contribute to barrier degradation and nutrient liberation from host tissues in the PD gut-brain context ^[48].

IBD (Crohn's Disease and Ulcerative Colitis)

• Mn, Ni, Zn, Se, and Sr generally lower in UC patients ^[49].
• ZIP8 A391T (Crohn's disease risk variant) reduces luminal Zn availability, inducing age-dependent microbiome shifts and spontaneous intestinal inflammation at 10 months ^[23].
• The altered luminal metal environment in Crohn's selects for microbes with enhanced metal acquisition — a zinc-mediated shift from commensal to pathogenic ecology.

Endometriosis (Excess)

Higher dietary zinc (>14 mg/day) associated with 60% increased odds of endometriosis (adjusted OR 1.6, 95% CI 1.12-2.27). This counterintuitive finding may operate through MMP activation: Zn-dependent MMP-2 and MMP-9 facilitate tissue invasion in endometriosis ^[7], ^[50].

Autoimmune Thyroid Disease

Zinc deficiency is associated with autoimmune thyroid conditions (Hashimoto's thyroiditis and Graves' disease) through impaired selenoprotein function, Th1/Th2/Treg imbalance, and metalloenzyme dependencies ^[51].

Behavioral and Neurodevelopmental Effects in Children

Heavy metal load and microbiome-associated metabolites account for 32% of variance in social behaviors among school-age children. The displacement of zinc by toxic metals (arsenic, cadmium, lead, mercury) from microbial enzyme binding sites may alter catecholamine precursor metabolite production via the gut-brain axis ^[52].

Interactions with Other Metals

The Irving-Williams Series: Why Zinc Outcompetes

The Irving-Williams series (Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II)) means zinc will outcompete weaker-binding metals (manganese, iron) for any given protein binding site if allowed free access ^[27]. Cells solve this by maintaining cytosolic metal concentrations in the inverse order — the weakest binders (Mn, Fe) are kept abundant, while the strongest binders (Cu, Zn) are kept at extremely low free concentrations (estimated at less than one free Cu(II) ion per cell) ^[27]. When metal stress exceeds this buffering capacity, the Irving-Williams hierarchy reasserts itself and mis-metallation cascades follow ^[27].

• copper: The most critical interaction. Cu and Zn compete for metallothionein binding and intestinal absorption. Cu displaces Zn from MT due to higher affinity. The Cu/Zn ratio is a pan-disease biomarker elevated in cancer, PCOS, ASD, and AMI ^[3].
• lead: Pb competes with Zn for binding sites on ~10% of human proteins. Pb exposure creates functional zinc deficiency — the proposed unifying mechanism in ASD ^[4].
• mercury: Hg competes with Zn for thiol-containing protein binding sites, contributing to functional Zn deficiency in the CNS.
• cadmium: Cd binds metallothionein and interferes with Zn homeostasis; Cd exposure can deplete Zn stores. Cd disrupts Ca/Zn/Fe homeostasis. In V. parahaemolyticus, the ZntA efflux pump handles both Zn and Cd ^[20].
• iron: Zn and Fe compete for intestinal absorption; co-supplementation may transiently reduce Fe absorption ^[11]. In V. parahaemolyticus, ferrous iron supplementation rescues growth under zinc excess, revealing functional cross-talk where Fe compensates for Zn homeostasis defects ^[20].
• manganese: The Zn:Mn ratio is the critical determinant for mis-metallation of Mn-dependent enzymes. In S. pneumoniae, Zn competitively inhibits Mn uptake via PsaA with an EC50 of 30.2 uM at 1 uM Mn ^[28]. Calprotectin restricts both Zn and Mn simultaneously at infection sites ^[24].
• Calcium: Both Zn and Ca are affected by toxic metal competition; Pb mimics Ca while displacing Zn. S. aureus can substitute calcium for manganese in its cell wall to survive metal chelation ^[53].
• Cobalt: Bacterial metal sensors can discriminate Zn from Co only within a narrow buffered range; exceeding this range causes mis-sensing with counterproductive transcriptional responses ^[26].

Biomarkers

Matrix	What It Reflects	Notes
Serum/plasma Zn	Current systemic status	Depleted in most cancers, T2D, PCOS, PPD, PD
Whole blood Zn	Total body zinc pool	Measured via ICP-MS in PCOS and ASD studies
Urinary Zn	Renal handling/excretion	Increased excretion in T2D; elevated in PDAC
Hair Zn	Medium-term status	Most consistent ASD finding (decreased), though with regional variability [41]
Cu/Zn ratio	Relative metal balance	Elevated in cancer, PCOS, ASD, AMI; pan-disease marker [3]
Zn isotopes (delta-66/64-Zn)	Metalloprotein dysregulation	Novel: PDAC patients excrete isotopically light Zn [38]
Fecal calprotectin	Intestinal inflammation / Zn sequestration	Elevated in IBD reflects Zn/Mn restriction at mucosal surface [24]
Melainabacteria abundance	Gut microbiome zinc status	AUC > 0.85 as microbial biomarker for zinc status [18]

Key Studies

Study	Year	Type	Key Contribution
[27]	2020	Review	Irving-Williams series framework for mis-metallation
[24]	2012	Review	Comprehensive map of nutritional immunity and pathogen metal acquisition
[1]	2024	Review	Defines metallostasis; ~33-40% of proteome is metalloprotein
[28]	2014	In-vitro	Zn:Mn ratio determines SOD mis-metallation in pneumococcus
[29]	2016	In-vitro	Mechanism of macrophage zinc poisoning via PerR mis-metallation
[25]	2014	In-vitro	Metal intoxication required for immune killing (60-100x Zn increase)
[2]	2025	Review	Three-way competition: host-pathogen-commensal metal warfare
[18]	2021	Animal	Dose-dependent zinc reshaping of gut microbiota
[23]	2024	Animal	Crohn's genetic variant alters zinc transport and microbiome
[6]	2024	Review	Zinc deficiency as hallmark of cancer across tumor types

Open Questions

1. Is zinc depletion cause or consequence? In cancer and T2D, is Zn deficiency a driver of disease or a result of altered Zn transporter expression and increased utilization?
2. Optimal supplementation dose: The PPD study used 100 mg/day while a negative study used 27 mg/day. What is the therapeutic dose threshold?
3. Endometriosis paradox: How can the same element be protective (antioxidant, immune) in most contexts but harmful (MMP activation) in endometriosis? Is dietary Zn a proxy for meat/shellfish consumption?
4. Zinc isotope biomarkers: Can zinc isotope fractionation be developed into a clinical diagnostic tool for early cancer detection?
5. Brain Zn paradox: Both Zn excess (plaque enrichment) and Zn deficiency (transporter dysfunction) are implicated in AD — what determines the direction of pathology?
6. Genetic susceptibility: Do ZIP/ZnT transporter polymorphisms (e.g., ZIP8 A391T in Crohn's, ZnT8 in T2D) define subpopulations that would benefit most from Zn intervention?
7. Hair vs serum/blood discrepancy in ASD: Does the lack of hair zinc difference found by Zhou et al. 2025 reflect matrix-specific differences, or regional/dietary confounders ^[41]?
8. Gut microbiome zinc sensing: Can Melainabacteria or Desulfovibrio abundance serve as non-invasive zinc status biomarkers in clinical practice ^[18]?
9. Co-selection risk: Does widespread zinc use in livestock feed and oral hygiene products drive clinically meaningful antibiotic resistance in human commensal bacteria ^[16]?
10. Iron-zinc cross-talk in pathogens: The finding that iron supplementation rescues zinc homeostasis defects in Vibrio ^[20] raises the question of whether dietary iron-zinc ratios shape pathogen virulence in the gut.

Cross-References

• copper — the most critical interaction; Cu/Zn ratio is a pan-disease biomarker
• lead — competes with Zn for binding sites; creates functional Zn deficiency
• mercury — competes with Zn for thiol groups; shared ASD mechanism
• cadmium — disrupts Zn homeostasis via metallothionein competition
• manganese — Zn:Mn ratio determines mis-metallation; calprotectin restricts both
• iron — absorption competition; Fe-Zn cross-talk in pathogen homeostasis
• nickel — co-measured in many studies; overlapping food sources
• arsenic — co-measured in metallomic panels; both altered in cancer
• chromium — Cr3+ and Zn both essential for glucose metabolism
• nutritional immunity — zinc sequestration (calprotectin) and flooding (phagosomal) as dual immune weapons
• mis metallation — zinc displaces Mn and Fe from enzymes via Irving-Williams series
• irving williams series — thermodynamic framework explaining zinc's competitive advantage
• calprotectin — primary host zinc/manganese-sequestering protein
• oxidative stress — Zn as SOD1 cofactor; Zn deficiency impairs antioxidant defense
• metal carcinogenesis — Zn deficiency as a general cancer feature
• metallomics — Zn as anchor element in cancer and ASD metallomic profiles
• gut microbiota — Zn deficiency and excess both reshape microbial composition
• antimicrobial resistance — zinc as co-selective pressure for antibiotic resistance
• siderophores metallophores — zincophores (pseudopaline) as bacterial zinc acquisition tools
• staphylococcus aureus — model organism for understanding nutritional immunity zinc battle
• streptococcus pneumoniae — Zn:Mn ratio mis-metallation paradigm
• pseudomonas aeruginosa — zincophore biology and zinc acquisition during CF lung infection